Literature DB >> 2683709

Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or nonspecific electrocardiograms (a report from the Multicenter Chest Pain Study).

G W Rouan1, T H Lee, E F Cook, D A Brand, M C Weisberg, L Goldman.   

Abstract

To determine the prevalence and characteristics of acute myocardial infarction (AMI) patients who present to emergency departments with normal or nonspecific electrocardiograms (ECGs), data were analyzed from 7,115 consecutive patients in the Multicenter Chest Pain Study. AMI patients with normal or nonspecific initial ECGs (n = 107) were less likely to have a past history of coronary artery disease or to be diaphoretic on presentation (p less than 0.01) than AMI patients with initial ECGs highly suggestive of AMI (n = 811). The overall probability of AMI among patients with chest pain and initially normal or nonspecific ECGs was 3%, but ranged from less than 1 to 17% depending on the patient's age and sex and whether the patient had pressure-type pain or pain radiating to the shoulder, neck or arms. Among initially admitted patients, the time elapsed between onset of pain and presentation was similar in both groups. However, the time between onset of pain and definitive diagnosis of AMI by enzymes or clinical course was longer in patients with initially normal or nonspecific electrocardiograms (8.3 vs 7.5 hours, p less than 0.05), their peak creatine kinase levels were lower (mean 643 vs 1,032 mg/dl, p less than 0.001) and their mortality was slightly lower (6 vs 12%, p = 0.10). These findings suggest that AMI patients with initially normal or nonspecific ECGs may have a less severe short-term clinical outcome.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2683709     DOI: 10.1016/0002-9149(89)90857-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  28 in total

1.  Five steps for ruling out coronary artery disease in general practice.

Authors:  Bartosz Hudzik; Janusz Szkodzinski; Lech Polonski
Journal:  CMAJ       Date:  2011-03-08       Impact factor: 8.262

2.  Reimbursement for chest-pain CT: estimates based on current imaging strategies.

Authors:  Hansel J Otero; Frank J Rybicki
Journal:  Emerg Radiol       Date:  2007-01-10

Review 3.  The role of CK-MB in chest pain decision-making.

Authors:  J R Hedges
Journal:  J Accid Emerg Med       Date:  1995-06

4.  Pitfalls in accident and emergency chest pain evaluation.

Authors:  J R Hedges
Journal:  J R Soc Med       Date:  1995-09       Impact factor: 5.344

Review 5.  The pathophysiology and epidemiology of myocardial infarction. A review.

Authors:  J Gill
Journal:  Drugs       Date:  1991       Impact factor: 9.546

6.  Correlates of major complications and mortality in patients presenting to the emergency department with chest pain and more than bibasilar rales.

Authors:  M H Chin; E F Cook; T H Lee; L Goldman
Journal:  J Gen Intern Med       Date:  1994-12       Impact factor: 5.128

7.  [Acute coronary syndromes without ST segment elevation].

Authors:  Helge Möllmann; Holger Nef; Christian W Hamm
Journal:  Herz       Date:  2009-02       Impact factor: 1.443

8.  Initial presenting electrocardiogram as determinant for hospital admission in patients presenting to the emergency department with chest pain: a pilot investigation.

Authors:  Prasanna K Challa; Karen M Smith; C Richard Conti
Journal:  Clin Cardiol       Date:  2007-11       Impact factor: 2.882

9.  Rapid diagnosis of myocardial injury with troponin T and CK-MB relative index.

Authors:  Gregory Engel; Stanley G Rockson
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

10.  Ruling out coronary heart disease in primary care patients with chest pain: a clinical prediction score.

Authors:  Baris Gencer; Paul Vaucher; Lilli Herzig; François Verdon; Christiane Ruffieux; Stefan Bösner; Bernard Burnand; Thomas Bischoff; Norbert Donner-Banzhoff; Bernard Favrat
Journal:  BMC Med       Date:  2010-01-21       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.